Douglas J. Swirsky
2020
In 2020, Douglas J. Swirsky earned a total compensation of $1.6M as Former President and Chief Executive Officer at Rexahn Pharmaceuticals, a 142% increase compared to previous year.
Compensation breakdown
| Salary | $343,542 |
|---|---|
| Other | $1,228,986 |
| Total | $1,572,528 |
Swirsky received $1.2M in other compensation, accounting for 78% of the total pay in 2020.
Swirsky also received $343.5K in salary.
Rankings
In 2020, Douglas J. Swirsky's compensation ranked 6,634th out of 13,090 executives tracked by ExecPay. In other words, Swirsky earned more than 49.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,634 out of 13,090 | 49th |
Division Manufacturing | 2,755 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,111 out of 2,254 | 51st |
Industry group Drugs | 961 out of 1,954 | 51st |
Industry Pharmaceutical Preparations | 720 out of 1,459 | 51st |
Source: SEC filing on April 26, 2021.
Swirsky's colleagues
We found three more compensation records of executives who worked with Douglas J. Swirsky at Rexahn Pharmaceuticals in 2020.